0720 GMT - Shares in pharmaceutical companies could come under selling pressure Monday after President Trump said he planned to cut U.S. prescription drug prices, with an announcement expected later Monday, Kathleen Brooks, research director at XTB writes. If Trump uses price caps on pharma imports rather than tariffs to reduce the cost for U.S. patients then this could have "big ramifications" for pharma companies and their profits, she says. AstraZeneca shares fall 4.2% in early trade, GSK loses 2.4% and Novo Nordisk drops 7.7%. (dominic.chopping@wsj.com)
(END) Dow Jones Newswires
May 12, 2025 03:20 ET (07:20 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.